SUTZX | VIGIX | SUTZX / VIGIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 3 years | 27 years | - |
Gain YTD | -0.823 | 1.373 | -60% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 5000000 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 67.1M | 292B | 0% |
Annual Yield % from dividends | 0.46 | 0.53 | 85% |
Returns for 1 year | -14.84 | 22.57 | -66% |
Returns for 3 years | -14.76 | 53.84 | -27% |
Returns for 5 years | N/A | 111.21 | - |
Returns for 10 years | N/A | 281.79 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYBOX | 58.38 | -0.21 | -0.36% |
Rydex Biotechnology A | |||
EPLIX | 21.88 | -0.18 | -0.82% |
NYLI Epoch U.S. Equity Yield Inv Class | |||
RMFCX | 57.23 | -0.62 | -1.07% |
American Funds American Mutual R3 | |||
GCTRX | 47.78 | -1.04 | -2.13% |
Goldman Sachs US Tax-Managed Eq R6 | |||
VLLIX | 38.78 | -1.25 | -3.12% |
Value Line Larger Companies Focus Instl |